ScholarIQanswers from OpenAlex

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

PaperCitations, authors & open-access status

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial have?

ScholarIQcitation count

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial has 675 citations in the OpenAlex counts ScholarIQ stores.

When was AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial published?

ScholarIQyear

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial has 2011 year in the ScholarIQ index.

What is the open-access status of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

ScholarIQoa status

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial has closed oa status in the ScholarIQ index.

What is the DOI of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

ScholarIQdoi

The DOI for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is on the source record.

What is the PMID of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

ScholarIQpmid

The PMID for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is on the source record.

What is the OpenAlex record for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial?

ScholarIQopenalex

The OpenAlex for AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial